Overview (26 Jul 2022)
Alkem Laboratories Ltd
ALKEM
INE540L01014

Pharmaceuticals
Result was last declared on 25 May 2021
-32.35

Prev. Close
Previous Close
3109.1
Current Close
3076.75
Current High
3114.5
Current Low
3060.15
52 Week High
4070
52 Week Low
2828
Resistance 1
3107.45
Resistance 2
3138.15
Support 1
3053.10
Support 2
2998.75
Std Deviation
2.67%
DMA 200
3399.39
DMA 50
3058.72
DMA 20
3082.69
Fundamentals and Ratios
Standalone
Trailing EPS
128.9
Forwad EPS
119.55
Trailing P/E
23.87
Forward P/E
25.74
PEG Ratio
-3.5473
Mkt. Cap (Cr)
Market Cap (Cr)
36787.16
Total Debt(Cr)
Tot. Debt(Cr)
1670.21
Reserve (Cr)
7352.82
Book Value
616.78
P/BV Ratio
4.99
ROCE(%)
20.00
ROE
24.00
Consolidated
Trailing EPS
137.63
Forwad EPS
131.31
Trailing P/E
23.06
Forward P/E
24.17
PEG Ratio
-5.26
Mkt. Cap (Cr)
Market Cap (Cr)
37949.33
Total Debt(Cr)
Tot. Debt(Cr)
1670.21
Reserve (Cr)
7352.82
Book Value
613.70
P/BV Ratio
5.17
ROCE(%)
21.00
ROE
26.00

 

Financial Result
Standalone
TypeMar-22Dec-21Sep-21Jun-21Mar-21FY21-22
Revenue2006.312180.842363.992278.671917.478829.81
Other Income54.2363.2443.2139.2148.77199.89
Total Income2060.542244.082407.202317.881966.249029.70
Interest13.087.268.509.067.3637.90
Expenditure-1874.71-1774.27-1838.47-1788.88-1557.80-7276.33
PBDT0.000.000.000.000.000.00
Depreciation-55.01-58.43-53.82-51.72-49.38-218.98
PBT185.83469.81568.73529.00395.661753.37
Tax-108.95-32.72-10.72-59.73-32.92-212.12
Equity0.000.000.000.000.000.00
OPM9.2621.5424.0623.2220.6319.00
Net Profit76.88437.09558.01469.27362.741541.25
NPM3.8320.0423.620.5918.9217
EPS6.4336.5646.6739.2530.34128.9
Consolidated
TypeMar-22Dec-21Sep-21Jun-21Mar-21FY21-22
Revenue2483.862618.982799.992731.362192.1610634.2
Other Income20.5253.5241.9646.6546.28162.65
Total Income2504.382672.502841.952778.012238.4410796.84
Interest16.9710.5711.9712.8610.7152.37
Expenditure-2246.74-2208.56-2260.41-2221.89-1980.28-8937.60
PBDT0.000.000.000.000.000.00
Depreciation-83.14-77.46-72.83-70.53-68.51-303.96
PBT242.68463.94581.54556.12258.161844.28
Tax-134.4769.41-23.01-75.89-8.94-163.96
Equity0.000.000.000.000.000.00
OPM9.6917.3620.4620.0211.5317.08
Net Profit108.21533.35558.53480.23249.221680.32
NPM4.3219.9619.6517.2911.1315.56
EPS943.9645.5239.1520.07137.63
Annual Reports

Corporate Action
Quarterly Result
Dividend
YearDividend TypeAmountRemarkEx Date
2021Final Dividend5.00Final Dividend - Rs. - 5.000009 Aug 2021
2021Interim Divvidend25.00Interim Dividend - Rs. - 25.000011 Feb 2021
2020Final Dividend3.00Final Dividend - Rs. - 3.000010 Aug 2020
2020Interim Divvidend22.00Interim Dividend - Rs. - 22.000013 Feb 2020
2019Final Dividend8.00Final Dividend - Rs. - 8.000019 Aug 2019
2019Interim Divvidend8.00Interim Dividend - Rs. - 8.000015 Feb 2019
2018Final Dividend7.00Final Dividend - Rs. - 7.000023 Aug 2018
2018Interim Divvidend6.00Interim Dividend - Rs. - 6.000016 Feb 2018
2017Final Dividend9.00Final Dividend - Rs. - 9.000031 Aug 2017
2017Interim Divvidend6.00Interim Dividend - Rs. - 6.000023 Nov 2016
2016Interim Divvidend9.70Interim Dividend - Rs. - 9.700018 Mar 2016
Bonus
Split
Sector: Pharmaceuticals
CompanyCurrent CloseP/E Ratio
AARTIDRUGS
430.4
20.46
ABBOTINDIA
19949.9
53.08
AJANTPHARM
1302.3
15.64
ALBERTDAVD
587.8
9.51
ALEMBICLTD
71.15
21.3
ALKEM
3173.95
24.62
AMBALALSA
30.4
77.95
ANUHPHR
92.2
15.11
APLLTD
707.85
17.53
AREYDRG
35.55
13.07
ARMOURPO
152.05
14.29
ASTRAZEN
3077.85
124.91
AUROLAB
88.2
19.34
AUROPHARMA
550.95
22.19
BAJAJHCARE
381.65
14.75
123456789
Connect @
Important Links
BSE
NSE
Copyright: IndiaOne Media 2020